REFERENCES
- Advisory Council on the Misuse of Drugs (ACMD). (2011). Consideration of the Novel Psychoactive Substances (‘Legal Highs’). Retrieved June 20, 2013, from: https: //www.gov.uk/ government/uploads/system/uploads/attachment_data/file/1191 39/acmdnps2011.pdf.
- Ahmed, A. H., & Oswald, R. E. (2010). Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. Journal of Medicinal Chemistry, 53(5), 2197–2203.
- Benesova, O. (1980). The effects of nootropic drugs on the susceptibility to audiogenic seizures in rats. Activitas Nervosa superior (Praha), 22, 192–193.
- Bersani, F. S., Corazza, O., Simonato, P., Mylokosta, A., Levari, E., Lovaste, R., & Schifano F. (2013). Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy. General Hospital Psychiatry, 35(5), 571–573.
- Brainmeta. Piracetam: Does it work, what are pros/cons? (2011). Retrieved July 12, 2013, from: http://brainmeta.com/ forum/index.php?showtopic=23425.
- Brandao, F., Cadete-Leite, A., Andrade, J. P., Madeira, M. D., & Paula-Barbosa, M. M. (1996). Piracetam promotes mossy fiber synaptic reorganization in rats withdrawn from alcohol. Alcohol, 13, 239–249.
- Brandao, F., Paula-Barbosa, M. M., & Cadete-Leite, A. (1995). Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake. Alcohol, 12, 279–288.
- Cohen, S. A., & Müller, W. E. (1993). Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain. Pharmacology, 47, 217–222.
- Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., … Schifano F. (2013). Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances (NPS) in the EU: The outcomes of the ReDNet project. Human Psychopharmacology, 28(4), 317–323.
- Corazza, O., Schifano, F., Deluca, P., Davey, Z., Torrens, M., Demetrovics, Z., … (2011). Designer drugs on the internet: A phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. Current Clinical Pharmacology, 6(2), 125–129.
- Danilova, E. I., Grafova, V. N., & Reshetniak, V. K. (1996). The action of piracetam and its complex with sodium oxybutyrate in the neuropathic pain syndrome. Eksperimental'naia i klinicheskaia farmakologiia, 59(4), 8–10.
- Drugs-forum. Another Piracetam Experiment … (2006b). Retrieved June 25, 2013, from: http://www.drugs-forum.com/ forum/showthread.php?t=136253.
- Drugs-forum. Cocaine and Piracetam. (2009b). Retrieved July 22, 2013, from: http://www.drugs-forum.com/forum/show thread.php?t=84660.
- Drugs-forum. High Dose piracetam My findings. (2011). Retrieved June 6, 2013, from: http://www.drugs-forum.com/forum/show thread.php?t=153468.
- Drugs-forum. Kratom Mitragyna speciosa. (2009a). Retrieved August 12, 2013, from: http://www.drugs-forum.com/forum/show thread.php?t=79493.
- Drugs-forum. LSD Piracetam combo. (2005). Retrieved July 11, 2013, from: http://www.drugs-forum.com/forum/showthread. php?t=6977.
- Drugs-forum. Nootropics Smartdrugs, Brain boosters & Cognitive enhancers. (2006a). Retrieved July, 2013, from: http:// www.drugs-forum.com/forum/showthread.php?t=136253.
- Erowid Experience Vault. Effects of Piracetam on MDMA, LSD, methamphetamine, and other drugs. (2001). Retrieved August 31, 2013, from: http://www.erowid.org/experiences/exp. php?ID=9126.
- Erowid Experience Vault. It rules!!! Piracetam. (2008). Retrieved July 23, 2013, from: http://erowid.org/experiences/exp. php?ID=68705.
- Erowid Experience Vault. Piracetam The effects. (2007). Retrieved June 30, 2013, from: http://erowid.org/experiences/exp. php?ID=53927.
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2010). Annual report on the state of the drugs problem in Europe. Lisbon; 2010. Retrieved August 1, 2013, from: http://www.emcdda.europa.eu/publications/annual-report/2010.
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2011). Annual report 2011 –the state of the drugs problem in Europe. Lisbon; Retrieved August 1, 2013, from: http://www.emcdda.europa.eu/publications/annual-report/2011.
- Evans-Brown, M., McVeigh, J., Perkins, C., & Bellis, M. (2012). Human enhancement drugs: The emerging challenges to public health. Centre for Public Health, Liverpool John Moores University.
- Fassoulaki, A., Kostopanagiotou, G., Kaniaris, P., & Varonos, D. D. (1985). Piracetam attenuates the changes in the surface potential of the phosphatidylcholine monolayer produced by alcohols. Acta anaesthesiologica Belgica, 36, 47–51.
- Giurgea, C. (1972). Towards an integrative pharmacology of the activity of the brain. Attempt at the nootropic concept in psychopharmacology. Actual Pharmacology (Paris), 25, 115–176.
- Graham, M. R., Ryan, P., Baker, J. S., Davies, B., Thomas, N. E., Cooper, S. M., … Kicman, A. T. (2009). Counterfeiting in performance- and image-enhancing drugs. Drug Testing and Analysis, 1(3), 135–142.
- Jordaan, B., Oliver, D. W., Dormehl, I. C., & Hugo, N. (1996). Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide. Arzneimittelforschung, 46(9), 844–847.
- Keller, M., Blench, M., Tolentino, H., Freifeld, C. C., Mandl, K. D., Mawudeku, A., … Brownstein, J. S. (2009). Use of unstructured event-based reports for global infectious disease surveillance. Emerging Infectious Diseases, 15(5), 689–695.
- Larance, B., Degenhardt, L., Copeland, J., & Dillon, P. (2008). Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug and Alcohol Review, 27(6), 679–686.
- Libov, I., Miodownik, C., Bersudsky, Y., Dwolatzky, T., & Lerner, V. (2007). Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: A randomized, double-blind, placebo-controlled crossover study. Journal of Clinical Psychiatry, 68(7), 1031–1037.
- Littlejohn, C., Baldacchino, A., Schifano, F., & Deluca, P. (2005). Internet pharmacies and online prescription drug sales: A cross-sectional study. Drugs: Education, Prevention, and Policy, 12, 75–80.
- Longecity. Learning aid: Piracetam vs. Modafinil. (2007). Retrieved July 18, 2013, from: http://www.longecity.org/forum/ topic/15948-learning-aid-piracetam-vs-modafinil/.
- Müller, W. E., Koch, S., Scheuer, D., Rostock, A., & Bartsch, R. (1997). Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochemical Pharmacology, 53, 135–140.
- Myhelpforum. Piracetam, farmaco nootropico. (2012). Retrieved June 13, 2013, from: http://myhelp.forumfree.it/?t=60144419.
- Nootrabiolabs. (2013). Retrieved August 1, 2013, from: http://www.nootrabiolabs.com/index.php?route=product/search&filter_name=piracetam.
- Nootropic reviews. Where to find piracetam bulk powder for sale. (2013). Retrieved July 20, 2013, from: http:// bestnootropic.org/piracetam-bulk-powder/.
- Orizio, G., Schulz, P., Domenighini, S., Caimi, L., Rosati, C., Rubinelli, S., & Gelatti, U. (2009). Cyberdrugs: A cross-sectional study of online pharmacies characteristics. European Journal of Public Health, 19(4), 375–377.
- Peuvot, J., Schank, A., Deleers, M., & Brasseur, R. (1995). Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis. Biochemical Pharmacology, 50, 1129–1134.
- Piracetam Review. Youtube video. (2011). Retrieved July 17, 2013, from: http://www.youtube.com/watch?v=XVxN8vRUu5g
- Piracetam Smart Drug Secret. (2010). Youtube video. Retrieved July 30, 2013, from: http://www.youtube.com/watch?feature= player_embedded&v=lWUnKAqcUdM#!
- Schifano, F., Corazza, O., Marchi, A., Di Melchiorre, G., Sferrazza, E., Enea, A., … Deluca, P. (2013). Psychonaut web mapping e rednet research projects. [Analysis of online reports on the potential misuse of benzidamine]. Rivista di Psichiatria, 48(3), 182–186.
- Schifano, F., D'Offizi, S., Piccione, M., Corazza, O., Deluca, P., Davey, Z., … Scherbaum, N. (2011). Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychotherapy and Psychosomatics, 80(2), 118–122.
- Schifano, F., Deluca, P., Baldacchino, A., Peltoniemi, T., Scherbaum, N., Torrens, M., … Ghodse, A. H. (2006). Drugs on the web; the Psychonaut 2002 EU project. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30(4), 640–646.
- Schifano, F., Leoni, M., Martinotti, G., Rawaf, S., & Rovetto, F. (2003). Importance of cyberspace for the assessment of the drug abuse market: Preliminary results from the Psychonaut 2002 Project. Cyberpsychology, Behavior, 6, 405–441.
- Smart drugs make learning easier. (2010). Youtube video. Retrieved July 26, 2013, from: http://www.youtube.com/watch?v= g7inflAWSWc.
- TGMOnline. (2008). Preparati Nootropi o Smart Drugs. Retrieved August 12, 2013, from: http://forum.tgmonline.it/showthread. php?154770-Preparati.
- Treato. (2013 Jul 7). Piracetam. Retrieved August 10, 2013, from: http://treato.com/Piracetam,Spacey/?a=s&p=7.
- US Food and Drug Administration (FDA). (2010). Inspections, Compliance, Enforcement, and Criminal Investigations. Retrieved September 19, 2012, from: http://www.fda.gov/ICECI/ EnforcementActions/WarningLetters/ucm225605.htm.
- Waegemans, T., Wilsher, C. R., Danniau, A., Ferris, S. H., Kurz, A., & Winblad, B. (2002). Clinical efficacy of piracetam in cognitive impairment: A meta-analysis. Dementia and Geriatric Cognitive Disorders, 13, 217–224.
- Winblad, B. (2005). Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Reviews, 11(2), 169–182.